Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 20

1.

A rapid and reliable test for BRCA1 and BRCA2 founder mutation analysis in paraffin tissue using pyrosequencing.

Zhang L, Kirchhoff T, Yee CJ, Offit K.

J Mol Diagn. 2009 May;11(3):176-81. doi: 10.2353/jmoldx.2009.080137. Epub 2009 Mar 26.

2.

Heterogenic loss of the wild-type BRCA allele in human breast tumorigenesis.

King TA, Li W, Brogi E, Yee CJ, Gemignani ML, Olvera N, Levine DA, Norton L, Robson ME, Offit K, Borgen PI, Boyd J.

Ann Surg Oncol. 2007 Sep;14(9):2510-8. Epub 2007 Jun 29.

PMID:
17597348
3.

Effects of BRCA1 transgene expression on murine mammary gland development and mutagen-induced mammary neoplasia.

Hoshino A, Yee CJ, Campbell M, Woltjer RL, Townsend RL, van der Meer R, Shyr Y, Holt JT, Moses HL, Jensen RA.

Int J Biol Sci. 2007 Apr 25;3(5):281-91.

4.

Accuracy of BRCA1 and BRCA2 founder mutation analysis in formalin-fixed and paraffin-embedded (FFPE) tissue.

Adank MA, Brogi E, Bogomolniy F, Wadsworth EA, Lafaro KJ, Yee CJ, Kirchhoff T, Meijers-Heijboer EJ, Kauff ND, Boyd J, Offit K.

Fam Cancer. 2006;5(4):337-42. Epub 2006 May 25.

PMID:
16724247
5.

Gene expression profiles associated with response to chemotherapy in epithelial ovarian cancers.

Jazaeri AA, Awtrey CS, Chandramouli GV, Chuang YE, Khan J, Sotiriou C, Aprelikova O, Yee CJ, Zorn KK, Birrer MJ, Barrett JC, Boyd J.

Clin Cancer Res. 2005 Sep 1;11(17):6300-10.

6.

Frequent mutation of the PIK3CA gene in ovarian and breast cancers.

Levine DA, Bogomolniy F, Yee CJ, Lash A, Barakat RR, Borgen PI, Boyd J.

Clin Cancer Res. 2005 Apr 15;11(8):2875-8.

7.

BRCA1-mediated repression of select X chromosome genes.

Jazaeri AA, Chandramouli GV, Aprelikova O, Nuber UA, Sotiriou C, Liu ET, Ropers HH, Yee CJ, Boyd J, Barrett JC.

J Transl Med. 2004 Sep 21;2(1):32.

8.

Fallopian tube and primary peritoneal carcinomas associated with BRCA mutations.

Levine DA, Argenta PA, Yee CJ, Marshall DS, Olvera N, Bogomolniy F, Rahaman JA, Robson ME, Offit K, Barakat RR, Soslow RA, Boyd J.

J Clin Oncol. 2003 Nov 15;21(22):4222-7. Review.

PMID:
14615451
9.

Gene expression profiles of BRCA1-linked, BRCA2-linked, and sporadic ovarian cancers.

Jazaeri AA, Yee CJ, Sotiriou C, Brantley KR, Boyd J, Liu ET.

J Natl Cancer Inst. 2002 Jul 3;94(13):990-1000.

PMID:
12096084
10.

Construction and characterization of recombinant adenoviruses expressing human BRCA1 or murine Brca1 genes.

Campbell M, Aprelikova ON, van der Meer R, Woltjer RL, Yee CJ, Liu ET, Jensen RA.

Cancer Gene Ther. 2001 Mar;8(3):231-9.

11.

Analysis of fibroblast growth factor receptor 3 S249C mutation in cervical carcinoma.

Yee CJ, Lin O, Boyd J.

J Natl Cancer Inst. 2000 Nov 15;92(22):1848-9. No abstract available.

PMID:
11078763
12.

Honeybee venom specific IgG subclass antibodies in Brazilian beekeepers and in patients allergic to bee stings.

Manso EC, Morato-Castro FF, Yee CJ, Croce M, Palma MS, Croce J.

J Investig Allergol Clin Immunol. 1998 Jan-Feb;8(1):46-51.

PMID:
9555620
13.

Acquired immunity to Africanized honeybee (Apis mellifera) venom in Brazilian beekeepers.

Yee CJ, Morato-Castro FF, Palma MS, Malaspina O, Azevedo Neto RS, Costa-Manso E, Croce J.

J Investig Allergol Clin Immunol. 1997 Nov-Dec;7(6):583-7.

PMID:
9491199
14.

Breast cancer and CYPIA1, GSTM1, and GSTT1 polymorphisms: evidence of a lack of association in Caucasians and African Americans.

Bailey LR, Roodi N, Verrier CS, Yee CJ, Dupont WD, Parl FF.

Cancer Res. 1998 Jan 1;58(1):65-70.

15.

High-mobility group (HMG) protein HMG-1 and TATA-binding protein-associated factor TAF(II)30 affect estrogen receptor-mediated transcriptional activation.

Verrier CS, Roodi N, Yee CJ, Bailey LR, Jensen RA, Bustin M, Parl FF.

Mol Endocrinol. 1997 Jul;11(8):1009-19.

PMID:
9212049
16.

Estrogen receptor gene analysis in estrogen receptor-positive and receptor-negative primary breast cancer.

Roodi N, Bailey LR, Kao WY, Verrier CS, Yee CJ, Dupont WD, Parl FF.

J Natl Cancer Inst. 1995 Mar 15;87(6):446-51.

PMID:
7861463
17.

Distinct morphological and mito-inhibitory effects induced by TGF-beta 1, HGF and EGF on mouse, rat and human hepatocytes.

Petersen B, Yee CJ, Bowen W, Zarnegar R, Michalopoulos GK.

Cell Biol Toxicol. 1994 Aug;10(4):219-30.

PMID:
7895151
18.

Microsatellite instability and loss of heterozygosity in breast cancer.

Yee CJ, Roodi N, Verrier CS, Parl FF.

Cancer Res. 1994 Apr 1;54(7):1641-4.

19.

Expression and characterization of biologically active human hepatocyte growth factor (HGF) by insect cells infected with HGF-recombinant baculovirus.

Yee CJ, DeFrances MC, Bell A, Bowen W, Petersen B, Michalopoulos GK, Zarnegar R.

Biochemistry. 1993 Aug 10;32(31):7922-31.

PMID:
8347597
20.

Microbial Toxicity Monitor for in Situ Continuous applications.

Shieh WK, Yee CJ.

Biotechnol Bioeng. 1985 Oct;27(10):1500-6. No abstract available.

PMID:
18553598

Supplemental Content

Support Center